GB1560903A - Intermediates for the preparation of 15 - deutro - protaglandins - Google Patents

Intermediates for the preparation of 15 - deutro - protaglandins Download PDF

Info

Publication number
GB1560903A
GB1560903A GB4324/79A GB432479A GB1560903A GB 1560903 A GB1560903 A GB 1560903A GB 4324/79 A GB4324/79 A GB 4324/79A GB 432479 A GB432479 A GB 432479A GB 1560903 A GB1560903 A GB 1560903A
Authority
GB
United Kingdom
Prior art keywords
deutero
acetic acid
lactone
octenyl
trans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4324/79A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1560903A publication Critical patent/GB1560903A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

PATENT SPECIFICATION
( 21) Application No 4324/79 ( 62) Divided out of No 1560 ( 31) Convention Application ( 32) Filed 25 June 1975 in ( 22) Filed 22 June 1976 902 No 8250/75 ( 11) 1 560 903 ( 19) ( 33) ( 44) ( 51) Switzerland (CH),
Complete Specification published 13 Feb 1980
INT CL 3 C 07 D 307/93 ( 52) Index at acceptance C 2 C 147 X 1672 200 213 215 220 226 22 Y 247 253 25 Y 28 X 300 Y 311 31 Y 351 352 360 362 364 366 368 36 Y 386 388 389 490 509 50 Y 623 624 625 628 633 634 652 662 668 672 67 X 694 699 761 767 AA TU ( 54) INTERMEDIATES FOR THE PREPARATION OF 15-DEUTERO-PROSTAGLANDINS ( 71) We, SANDOZ LTD, 35 Lichtstrasse, CH-4002 Basle, Switzerland, a Swiss body corporate, do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:-
The present invention relates to intermediates for the preparation of 15 deuteroprostaglandins.
In accordance with the invention there are provided compounds of formula V, F -' V D OR 4 wherein C is a prostaglandin end group, F is F 2 F 1 0 9 o or OR 5 F 3 and R, and R, are, independently, hydrogen or an acid sensitive protecting group.
The compounds of formula V are, by virtue of the presence of the lactone group, useful as intermediates in one stage of the synthesis for the preparation of the compounds of formula I as described and claimed in our copending application No 25886/76, (Serial No 1,560,902) filed 22nd June, 1976.
The compounds for formula V can be obtained by deuterating a compound of formula VI, FIV 3, 0 wherein C is as defined above, and F' is Fl, F 2, F 3, as previously defined, or F 4 wherein R is hydrogen or a bulky group capable of influencing the proportion of a:, alcohol formed, and, if necessary, converting any group R 7 present into a group R, as previously defined, and if desired, protecting the 3-hydroxy group with an acid sensitive protecting group.
As indicated by the broken lines in formula VI, the 1 and 2 carbon atoms may be linked by a single bond or a trans double bond.
The reaction may be carried out in conventional manner for such deuterations bearing in mind the other groups present For example a deuterating agent such as sodium or zinc borodeuteride may be used An anhydrous inert organic solvent such as dimethyl formamide or dimethoxyethane may be present.
Suitable temperatures are between -40 and C Preferably the reaction is effected under an inert gas atmosphere.
The a and B/-alcohols which may both be formed may be separated in conventional manner.
The group R, may be chosen such that it influences by virtue of its size the proportion of a: i? alcohol formed generally increasing the amount of a-alcohol.
Such groups are well known in the art.
An example of a suitable protecting group R, is para-phenylbenzovl or benzoyl Such groups are split off under alkaline conditions, and may be exchanged for a group R in conventional manner.
The 3-hydroxy group may be protected in conventional manner.
4 M 2 L 560903 The compounds of formula VI can be obtained in accordance with known methods.
EXAMPLE 1 (-) -22 ( 3 ' deutero 3 'Y hydroxy4 ',4 ' dimethyl trans 1 ' octenyl)a hydroxy 3 a para phenyl benzoyloxy 1 l cyclopentyl acetic acid y lactone and (-) 2 ( 3 'deutero 3 '1 fhydroxy 4 ',4 ' dimethyl trans 1 ' octenyl) 5 ahydroxy 3 a para phenylbenzoyloxyla cyclopentyl acetic acid y-lactone (intermediate compounds of formula V' wherein the compounds of formula V possess a bulky group R 7 in the moiety F 4) A solution of 1 45 g of (-) 5 a hydroxy2,8 ( 3 'oxo 4 ',4 'dimethyl trans 1 'octenyl) 3 a para phenylbenzoyl oxyla cyclopentyl acetic acid y-lactone in 8 ml of absolute dimethoxyethane at -15 C in a nitrogen atmosphere Stirring is subsequently effected at 3 to 5 C for 3 5 hours and at to 10 C for one hour The mixture is then again cooled at -15 C and 3 ml of an aqueous 10 % (w/v) sodium hydrogen tartrate solution are slowly added The mixture is extracted with 2 x 100 ml of diethyl ether The organic phase is washed with 100 ml of a saturated aqueous sodium chloride solution, dried with sodium sulphate and concentrated by evaporation at reduced pressure, whereby a mixture of the corresponding a and j 3 isomers is obtained The residue is chromatographed on 50 g of neutral silica gel, whereupon the a and then the fl-isomer is eluted with chloroform ( 5 % ethyl acetate).
a-isomer:
Thin layer chromatography (Silica gel):
Methylene chloride ( 5 % acetic ester) Rf= 0 4, M Pt 107-108 C.
IR (methylene chloride) inter alia bands at: 3500, 1770, 1710, 1660 cm-.
/3-isomer:
Thin layer chromatography (Silica gel):
Methylene chloride ( 5 % acetic ester) Rf= O 3.
Spectral data approximately as for aisomer.
The following compounds of formula V can be prepared in manner analogous to that employed for the title compound of Example 1, using appropriate starting materials in approximately equivalent amounts:
2 2,8 ( 3 ' deutero 3 ',B hydroxy 4,4dimethyl trans 1 ' octenyl) 3 a,5 adihydroxy la cyclopentyl acetic acid r-lactone.
3. 2,B ( 3 'deutero 3 'a hydroxy trans1 ' octenyl) 3 a Sa dihydroxy lacyclopentyl acetic acid y lactone.
4. 24 ( 3 ' deutero 3 ',/ hydroxytrans 1 ' octenyl) 3 a,5 adihydroxyla cyclopentyl acetic acid y lactone.
5. 2/? ( 3 'deutero 3 'a hydroxy 4 ' 65 methyl trans 1 ' octenyl) 3 a,5 rdihydroxy la cyclopentyl acetic acid y lactone.
6. 243 ( 3 ' deutero 3 'Y hydroxy 4 'methyl trans 1 ' octenyl) 3 a,5 a 70 hydroxy la cyclopentyl acetic acid 3 y lactone.
7. 2 J ( 3 ' deutero 4,4 dimethyl 3 'ahydroxy trans 1 ' octenyl) a 5hydroxy la cyclopent 2 enyl acetic acid 75 y lactone.
8 2,B ( 4 N -butyl 3 ' deutero 3 'Shydroxy trans 1 ' octenyl) 3 a,5dihydroxy la cyclopentyl acetic acid y lactone 80 9 24 ( 4 N butyl 3 ' deutero 3 'Shydroxy trans 1 ' octenyl) 5 ahydroxy la cyclopent 3 enyl acetic acid y lactone.
2,8 ( 3 ' deutero 3 'R hydroxy 4 R 85 methyl trans 1 ' octenyl) 3 a,5 adihydroxy la cyclopentyl acetic acid y lactone.
11 24 ? ( 3 ' deutero 3 'R hydroxy 4 'methyl 4 ' l 3 " trifluoro methyl 90 phenoxyl trans 1 pentenyl) 3 a,5 adihydroxy la cyclopentyl acetic acid y lactone.
12 2/? ( 3 ' deutero 3 'S hydroxytrans 1 ' octenyl) 3 a,5, dihydroxy 95 la cyclopentyl acetic acid y lactone.
13 2/3 ( 3 'deutero 3 'S hydroxy trans1 ' octenyl) 5 a hydroxy 1 e cyclopent 3 enyl acetic acid y lactone.
14. 2 _ 8( 3 'deutero 3 'a hydroxy octyl) 100 a hydroxy la cyclo pentyl acetic acid y lactone.
15. 2/ ( 3 'deutero 3 'a hydroxy 4 '( 3 " trifluoromethyl phenoxy) trans1 butenyl) 3 a,5 a dihydroxy la 105 cyclo pentyl acetic acid y lactone.

Claims (1)

  1. WHAT WE CLAIM IS:-
    1 A compound of formula V, wherein C is a F is F 1 ' F 1 OR 4 prostaglandin end group, V F 2 F 3 obtained in (+) racemic form and in 3 'R or 3 'S optically active form The compounds of examples 5 and 6 may be obtained as the 4 'a-methyl isomer or the 4 'g-methyl isomer.
    1.560903 " 7 1,560,903 and RP and R 5 are, independently, hydrogen or an acid sensitive protecting group.
    2 (-) 2,/3 ( 3 'deutero 3 'a hydroxy4 ',4 ' dimethyl trans 1 ' octenyl) 5 ahydroxy 3 a para phenyl benzoyloxyla cyclopentyl acetic acid y lactone and (-) 2,5 ( 3 ' deutero 3 ',, hydroxy4 ',4 'dimethyl trans 1 ' octenyl) Sahydroxy 3 a paraphenylbenzoyloxy la cyclopentyl acetic acid y lactone.
    3 24 ? ( 3 'deutero 3 '1 hydroxy 4 ',4 'dimethyl trans 1 ' octenyl 3 a,5 a dihydroxy la cyclopentyl acetic acid ylactone.
    4 ZO ( 3 'deutero 3 'a hydroxy trans1 ' octenyl) 3 a,5 a dihydroxy la cydclopentyl acetic acid y lactone.
    2,83 ( 3 'deutero 3 'Y,hydroxy trans1 ' octenyl) 3 a,5 a dihydroxy l cyclopentyl acetic acid y lactone.
    6 2,5 ( 3 'deutero 3 'a hydroxy 4 'methyl trans 1 ' octenyl) 3 a,5 Sa dihydroxy la cyclopentyl acetic acid y lactone.
    7 25 ( 3 'deutero 3 ',B hydroxy 4 'methyl trans 1 ' octenyl) 3 a,5 a dihydroxy la cyclopentyl acetic acid y lactone.
    8 2,8 ( 3 ' deutero 4,4 dimethyl 3 'rahydroxy trans 1 ' octenyl) 5 a hydroxyla cyclopent 2 enyl acetic acid y lactone.
    9 23 ( 4 N butyl 3 ' deutero 3 'Shydroxy trans 1 ' octenyl) 3 a,5 dihydroxy la cyclopentyl acetic acid y lactone.
    2,3 ( 4 N butyl 3 ' deutero 3 'Shydroxy trans 1 ' octenyl) 5 a hydroxyla cyclopent 3 enyl acetic acid y lactone.
    11 2/3 ( 3 'deutero 3 'R hydroxy 4 Rmethyl trans 1 ' octenyl) 3 a,5 xt dihydroxy 1,a cyclopentyl acetic acid y lactone.
    12 2,, ( 3 'deutero 3 'R hydroxy 4 'methyl 4 ' l 3 " trifluoro methylphenoxyl trans 1 pentenyl) 3 a,5 a dihydroxy la cyclopentyl acetic acid y lactone.
    13 23 ( 3 ' deutero 3 'S hydroxytrans 1 ' octenyl) 3 a,5,a dihydroxy lcyclopentyl acetic acid y lactone.
    14 26 ( 3 ' deutero 3 'S hydroxytrans 1 ' octenyl) 5 a hydroxy lacyclopent 3 enyl acetic acid y lactone.
    2/3 ( 3 ' deutero 3 'a hydroxyoctyl) 5 a hydroxy la cyclo pentyl acetic acid y lactone.
    16 2,3 ( 3 'deutero 3 'a hydroxy 4 '( 3 " trifluoromethyl phenoxyl trans 1butenyl) 3 a Sa dihydroxy la cyclopentyl acetic acid y lactone.
    B A YORKE & CO, 98, The Centre, Feltham, Middx.
    Printed for Her Majesty's Stationery Office, by the Courier Press, Leamington Spa, 1980 Published by The Patent Office, 25 Southampton Buildings, London, WC 2 A l AY, from which copies may be obtained.
GB4324/79A 1975-06-25 1976-06-22 Intermediates for the preparation of 15 - deutro - protaglandins Expired GB1560903A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH825075 1975-06-25

Publications (1)

Publication Number Publication Date
GB1560903A true GB1560903A (en) 1980-02-13

Family

ID=4337463

Family Applications (2)

Application Number Title Priority Date Filing Date
GB4324/79A Expired GB1560903A (en) 1975-06-25 1976-06-22 Intermediates for the preparation of 15 - deutro - protaglandins
GB25886/76A Expired GB1560902A (en) 1975-06-25 1976-06-22 15 - deutero-prostaglandin derivatives methods for their preparation and compositions containing said derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB25886/76A Expired GB1560902A (en) 1975-06-25 1976-06-22 15 - deutero-prostaglandin derivatives methods for their preparation and compositions containing said derivatives

Country Status (19)

Country Link
JP (1) JPS523039A (en)
AT (1) ATA460476A (en)
AU (1) AU511527B2 (en)
BE (1) BE843318A (en)
CA (1) CA1095032A (en)
DD (1) DD124727A5 (en)
DE (1) DE2626582A1 (en)
DK (1) DK270176A (en)
ES (1) ES449147A1 (en)
FI (1) FI761741A (en)
FR (2) FR2316930A1 (en)
GB (2) GB1560903A (en)
IL (1) IL49889A (en)
NL (1) NL7606709A (en)
NO (1) NO762102L (en)
NZ (1) NZ181264A (en)
PT (1) PT65265B (en)
SE (1) SE7606972L (en)
ZA (1) ZA763810B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59161476U (en) * 1983-04-14 1984-10-29 富士重工業株式会社 Expansion valve control structure in refrigeration cycle

Also Published As

Publication number Publication date
PT65265A (en) 1976-07-01
IL49889A0 (en) 1976-08-31
GB1560902A (en) 1980-02-13
AU511527B2 (en) 1980-08-21
CA1095032A (en) 1981-02-03
IL49889A (en) 1979-11-30
FI761741A (en) 1976-12-26
ES449147A1 (en) 1977-12-01
FR2316930A1 (en) 1977-02-04
AU1532676A (en) 1978-01-05
FR2316930B1 (en) 1978-11-17
FR2351974A1 (en) 1977-12-16
PT65265B (en) 1978-03-24
SE7606972L (en) 1976-12-26
BE843318A (en) 1976-12-23
NO762102L (en) 1976-12-28
NL7606709A (en) 1976-12-28
NZ181264A (en) 1978-07-10
JPS523039A (en) 1977-01-11
FR2351974B1 (en) 1980-08-14
DE2626582A1 (en) 1977-03-03
ATA460476A (en) 1982-01-15
DD124727A5 (en) 1977-03-09
DK270176A (en) 1976-12-26
ZA763810B (en) 1978-02-22

Similar Documents

Publication Publication Date Title
Glass et al. Furanoid fatty acids from fish lipids
EP0045118A2 (en) Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2Z-enes
Naya et al. The structural elucidation of sesquiterpene lactones from Petasites japonicus Maxim
König et al. New C15 acetogenins and sesquiterpenes from the red alga Laurencia sp. cf. L. gracilis
Hoffmann et al. On the absolute stereochemistry of C-2 and C-3 in stegobinone
Segre et al. A new synthesis of 6-thioctic acid (DL-α-lipoic acid)
US4454330A (en) Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same
Patil et al. Chemistry of ayurvedic crude drugs—III: Guggulu (resin from Commiphora mukul)-3 long-chain aliphatic tetrols, a new class of naturally occurring lipids
Tanaka et al. A short synthesis of (−)-prostaglandin E1
EP0043479A1 (en) Novel cyclopentenone derivatives and methods for the preparation of the novel compounds
Inatani et al. Structure and Synthesis of New Phenolic Amides from Piper nigrum L.
Chikashita et al. Stereoselective syn-reduction of (R)-4-acyl-2, 2-dimethyl-1, 3-dioxolanes with metal hydride reagents
Aristoff et al. Synthesis of benzopyran prostaglandins, potent stable prostacyclin analogs, via an intramolecular Mitsunobu reaction
GB1560903A (en) Intermediates for the preparation of 15 - deutro - protaglandins
Arai et al. Oxidative Generation of 1-Nitroalkyl Radicals and Their Addition Reaction to Olefins.
KR0144684B1 (en) Mono esters of dicarboxylic acids and their prepartion and use
Todoroki et al. Ring conformational requirement for biological activity of abscisic acid probed by the cyclopropane analogues
Millar et al. Synthesis of the stereoisomers of the female sex pheromone of the Hessian fly, Mayetiola destructor
Stang et al. Vinyl triflates in synthesis. II. 1, 1-Di-, tri-, tetrasubstituted and deuterio allenes from ketones via vinyl triflates
Takagi et al. The components of Petasites japonicus Maxim. IV. The structure of petasitin.
Isoe et al. Synthesis of optically active petiodial and determination of its absolute structure
EP0010761B1 (en) Process for preparing 4-hydroxy-2-cyclopenten-i-ones, 2-methyl-2,5-dimethoxy-2,5-dihydrofurans and a process for their preparation
FILLER et al. Chemistry of Lactones. V. Reaction of α-Benzylidene-γ-phenyl-Δβ, γ-butenolide with Phenylmagnesium Bromide and Phenyllithium
Mori et al. Synthesis of both 2, 3-erythro-and 2, 3-threo-isomers of aplidiasphingosine, a bioactive marine terpenoid
Schulz Absolute Configuration and Synthesis of 2‐Hydroxy‐2‐(1‐hydroxyethyl)‐3‐methyl‐γ‐butyrolactone, a Presumed Pheromone of Ithomiine Butterflies

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee